BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 16358241)

  • 21. Acute mixed cellular and humoral rejection of renal allograft with leucopenia.
    Agarwal DK; Hota JK; Malhotra V
    J Assoc Physicians India; 2011 Aug; 59():524-6. PubMed ID: 21887916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-T-cell antibodies for the treatment of acute rejection after renal transplantation.
    van den Hoogen MW; Hoitsma AJ; Hilbrands LB
    Expert Opin Biol Ther; 2012 Aug; 12(8):1031-42. PubMed ID: 22583145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Higher graft salvage rate in renal allograft rupture associated with acute tubular necrosis.
    Sanchez de la Nieta MD; Sánchez-Fructuoso AI; Alcázar R; Pérez-Contin MJ; Prats D; Grimalt J; Blanco J
    Transplant Proc; 2004 Dec; 36(10):3016-8. PubMed ID: 15686684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant immunosuppression in renal transplantation: high dose intravenous steroids, local radiation therapy, and antilymphocyte globulin.
    Turcotte JG; Freier DT; Dickerman R
    Urol Clin North Am; 1976 Oct; 3(3):597-610. PubMed ID: 790733
    [No Abstract]   [Full Text] [Related]  

  • 25. Preoperative single-bolus high-dose antithymocyte globulin as induction therapy in sensitized renal transplant recipients.
    Wang D; Wu WZ; Yang SL; Chen JH; Tan JM
    Chin Med J (Engl); 2006 Oct; 119(20):1683-8. PubMed ID: 17097014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucormycosis in transplant patients.
    Fisher J; Tuazon CU; Geelhoed GW
    Am Surg; 1980 May; 46(5):315-22. PubMed ID: 6992671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Refractory humoral cardiac allograft rejection successfully treated with a single dose of rituximab.
    Baran DA; Lubitz S; Alvi S; Fallon JT; Kaplan S; Galin I; Correa R; Courtney MC; Chan M; Spielvogel D; Lansman SL; Gass AL
    Transplant Proc; 2004 Dec; 36(10):3164-6. PubMed ID: 15686719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of living-related renal transplant from the donor with membranous nephropathy.
    Akioka K; Okamoto M; Ushigome H; Nobori S; Suzuki T; Sakai K; Sakamoto S; Urasaki K; Yanagisawa A; Fukatsu A; Yoshimura N
    Clin Transplant; 2009 Aug; 23 Suppl 20():62-6. PubMed ID: 19594600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical significance of early diagnose and treatment of subclinical renal allograft rejection].
    Zeng JH; Yu LX; Luo HH; Wang XC; Wang X; Fang W
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):697-8. PubMed ID: 16762888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytomegalovirus and Clostridium difficile ischemic colitis in a renal transplant recipient: a lethal complication of anti-rejection therapy?
    Veroux M; Puzzo L; Corona D; Buffone A; Tallarita T; Murabito P; Veroux P
    Urol Int; 2007; 79(2):177-9; discussion 180. PubMed ID: 17851290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary mucormycosis in a nondiabetic renal allograft recipient successfully managed by medical therapy alone.
    Chacko B; David VG; Tamilarasi V; Deepti AN; John GT
    Transplantation; 2007 Jun; 83(12):1656-7. PubMed ID: 17589353
    [No Abstract]   [Full Text] [Related]  

  • 32. Successful treatment of mucormycosis after kidney transplantation.
    Miladipour A; Ghanei E; Nasrollahi A; Moghaddasi H
    Iran J Kidney Dis; 2008 Jul; 2(3):163-6. PubMed ID: 19377232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoglobulin therapy for plasma cell-rich rejection in the renal allograft.
    Adrogue HE; Soltero L; Land GA; Ramanathan V; Truong LD; Suki WN
    Transplantation; 2006 Aug; 82(4):567-9. PubMed ID: 16926602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors influencing long-term outcomes following renal transplantation: a review.
    Shrestha BM; Haylor JL
    JNMA J Nepal Med Assoc; 2007; 46(167):136-42. PubMed ID: 18274571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunologic monitoring of antithymocyte globulin treatment for acute allograft rejection.
    Delmonico FL; Nelson PW; Colvin RB; Cosimi AB
    Transplant Proc; 1984 Dec; 16(6):1492-3. PubMed ID: 6390852
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of antithymocyte globulin for reversal of acute allograft rejection.
    Shield CF; Cosimi AB; Tolkoff-Rubin N; Rubin RH; Herrin J; Russell PS
    Transplantation; 1979 Dec; 28(6):461-4. PubMed ID: 390784
    [No Abstract]   [Full Text] [Related]  

  • 37. Preserving renal function in liver transplant recipients with rabbit anti-thymocyte globulin and delayed initiation of calcineurin inhibitors.
    Bajjoka I; Hsaiky L; Brown K; Abouljoud M
    Liver Transpl; 2008 Jan; 14(1):66-72. PubMed ID: 18161842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calciphylaxis-associated second renal graft failure and patient loss: a case report and review of the literature.
    Aabed G; Al Furayh O; Al-Lehbi A; Al Mana H; Al Ghamedi A; Helmy A
    Exp Clin Transplant; 2008 Dec; 6(4):287-93. PubMed ID: 19338491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allograft mucormycosis due to Rhizopus microsporus in a kidney transplant recipient.
    Park W; Jang M; Hwang E; Han S; Park S; Kim H; Choe M
    Transplant Proc; 2014; 46(2):623-5. PubMed ID: 24656029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Avoiding steroids in pediatric renal transplantation: long-term experience from a single centre.
    Pedersen EB; El-Faramawi M; Foged N; Larsen KE; Jespersen B
    Pediatr Transplant; 2007 Nov; 11(7):730-5. PubMed ID: 17910649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.